Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.About Bunge Global Innovation LLC Bunge Global Innovation is an interdisciplinary team applying the latest thinking and technologies to drive innovation across all Bunge business segments. Its mission is to scout, develop, buy, sell or license technologies that will improve Bunge’s sustainability, profitability and competitive advantage. About Bunge Limited Bunge Limited ( www.bunge.com, NYSE: BG) is a leading global agribusiness and food company operating in over 40 countries with approximately 35,000 employees. Bunge buys, sells, stores and transports oilseeds and grains to serve customers worldwide; processes oilseeds to make protein meal for animal feed and edible oil products for commercial customers and consumers; produces sugar and ethanol from sugarcane; mills wheat, corn and rice to make ingredients used by food companies; and sells fertilizer in South America. Founded in 1818, the company is headquartered in White Plains, New York. Forward Looking Statements This press release contains certain forward-looking statements about Solazyme, including statements that involve risks and uncertainties concerning: its ability to finalize the BNDES loan; the nature of the final terms of that loan; the ability of the Solazyme Bunge joint venture to draw-down all or any funds from that loan; the ability of the Moema plant to produce tailored oils; the character of the oils produced at that plant; the value of such oils; the value that Solazyme’s technology can bring to the Brazilian economy; the timing of the commencement of operations at the Moema plant; the eventual capacity of such plant; the oils that will be produced at the plant and the industries and jurisdictions it will supply; eventual manufacturing capacity expansion by Solazyme and Bunge; the timing of any such expansion; and Solazyme's ability to maintain its relationships with its partners. When used in this press release, the words "will", "expects", "intends" and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme's limited operating history; its limited history in commercializing products; implementation risk in deploying new technologies; its limited experience in constructing and operating commercial manufacturing facilities; delays or inability to construct or start-up production facilities, including those associated with delay or inability to acquire the facility site; its access to adequate supply of feedstock on favorable terms; its ability to manage operational costs at production facilities; its ability to enter into and maintain strategic collaborations; its ability to obtain requisite regulatory approvals; and its ability to access, on favorable terms, the required financing. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.
In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.